CogniCurrent

COGNICURRENT

Jan 13 • 14:25 UTC • 🇶🇦 Qatar • Al Jazeera

The European Union approves a drug that slows the development of type 1 diabetes

The European Commission has approved the marketing of 'Tizeld', the first drug to officially impact the progression of type 1 diabetes in the EU, as announced by the French manufacturer Sanofi.

#diabetes #european union #health #sanofi #tizeld
Read Original Back to Feed

📡 Similar Coverage